Jeymi Tambiah has a diverse background in both clinical research and medical affairs, with experience at companies like Biosplice Therapeutics, Samumed, and UCB. With a strong educational foundation in medicine and surgery from institutions like the University of Manchester and the Royal College of Surgeons, Jeymi holds a Doctorate degree in Immunology and atherosclerosis from Imperial College London. Tambiah's expertise spans various areas such as immunology, pharmaceutical medicine, and clinical research, making them a valuable asset in the field.
Current role